ILMN

Illumina Inc., which makes genetic-variation measuring equipment, said Tuesday it swung to a third-quarter profit as sales of instruments soared.

The company earned $16.2 million, or 32 cents per share, compared with a loss of $1.4 million, or 3 cents per share, a year ago. Analysts polled by Thomson Financial expected earnings of 16 cents per share.